Who owns BRAINSTORM CELL THERAPEUTICS?
- Ticker: BCLI
- CUSIP Number: 10501e300
Tip: Access positions for across all investors
Analyze quarterly positions in Brainstorm Cell Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Brainstorm Cell Therapeutics stock
Who bought or sold BRAINSTORM CELL THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Caldwell Sutter Capital | 157k | $0 | 100% | Dec 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 747.00 | $1.7k | -93% | Dec 2024 |
|
| Cranbrook Wealth Management | 66.00 | $149.998200 | 100% | Dec 2024 |
|
| Bogart Wealth | 34.00 | $8.000200 | 100% | Sep 2024 |
|
| D. J. St. Germain | 33.00 | $74.999100 | -93% | Dec 2024 |
|
| Westside Investment Management | 12.00 | $27.999600 | 100% | Dec 2024 |
|
Who sold out of Brainstorm Cell Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Abner, Herrman & BrocK | Sep 2024 | 146k | $34k |